Cns Pharmaceuticals Inc (CNSP)

$0.21 0.004 (1.90%)

16:00 EDT CNSP Stock Quote Delayed 30 Minutes

CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023

By InvestorPlace Earnings Apr 1, 2024

CNS Pharmaceuticals just reported results for the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 78,498

Day's Range $0.20 - $0.22

52-Week Range $0.19 - $2.98

Dividend & Yield N/A (N/A)

CNSP Stock Predictions, Articles, and Cns Pharmaceuticals Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 18, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Apr 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 12, 2023

Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Nov 29, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers with the shares rising and falling on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 24, 2022

Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 19, 2022

Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Mar 3, 2022

Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 13, 2022

Good morning, investor! We're starting off the day right with a look at the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 6, 2022

Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

CNS Pharmaceuticals prices $4M public offering (NASDAQ:CNSP)

From Seeking Alpha Jan 30, 2024

CNS Pharmaceuticals announces public offering of 13.3 million shares at $0.30 per share, accompanied by Series A and Series B Warrants.

CNS Pharmaceuticals files to sell 3.81M shares of common stock (NASDAQ:CNSP)

From Seeking Alpha Dec 8, 2023

Read about CNS Pharmaceuticals' filing of a prospectus for the sale of 3.81M common stock.

CNS Pharmaceuticals files to sell 3.76M shares of common stock for holders (NASDAQ:CNSP)

From Seeking Alpha Nov 20, 2023

CNS Pharmaceuticals (CNSP) files prospectus for the offer and resale of 3.76M shares of common stock, but it is not an offer to sell.

Moleculin investigating possible illegal trading of its shares (NASDAQ:MBRX)

From Seeking Alpha Aug 7, 2023

Moleculin (MBRX) said that it has retained analytics firm Shareholder Intelligence Services, or ShareIntel, to investigate possible naked short selling of its shares. Read more here.

CNS Pharma announces positive dats from glioblastoma multiforme treatment trial (NASDAQ:CNSP)

From Seeking Alpha Dec 8, 2022

CNS Pharma (CNSP) announced preliminary results from its ongoing trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme ((GBM)).The results reflected...

CNS Pharmaceuticals: Q1 Earnings Insights

From Benzinga May 16, 2022

CNS Pharmaceuticals (NASDAQ:CNSP) reported its Q1 earnings results on Monday, May 16, 2022 at 08:35 AM. Here's what investors need to know about the announcement.

ADVERTISEMENT